Main Navigation Menu

• Cancer Information
• Cancer News
• Message Board

Ipsogen Announces Three Studies Extending The Utility Of The Genomic Grade Index For Predicting Response To Chemotherapy In Breast Cancer

IPSOGEN SA (Marseille and New Haven), a cancer profiler that develops and markets molecular diagnostic assays for blood & breast cancers, announced that researchers from the University of Texas MD Anderson Cancer Center (MDACC, Houston, TX) will present the results of two studies on the Genomic Grade index (GGi) at the ASCO Annual Meeting, held in Chica...

Cancer News Categories

Cancer News Topics

• All Cancer News
• Cancer Nutrition

Cancer Specific News

• Breast
• Colorectal
• Gynecological
• Hematological
• Lung
• Prostate
• Pancreatic
• Other

Access Our Feeds

Access Our Podcasts

Did You Know?

CancerCompass^SM publishes up to 50 new cancer news articles every week! Members can get these articles emailed to them on a weekly basis.